|
PART 1 Pharmacology Basics |
|
|
1 | (134) |
|
1 The Nursing Process and Drug Therapy |
|
|
1 | (12) |
|
2 Pharmacologic Principles |
|
|
13 | (20) |
|
3 Lifespan Considerations |
|
|
33 | (13) |
|
4 Cultural, Legal, and Ethical Considerations |
|
|
46 | (14) |
|
5 Medication Errors: Preventing and Responding |
|
|
60 | (12) |
|
6 Patient Education and Drug Therapy |
|
|
72 | (12) |
|
7 Over-the-Counter Drugs and Herbal and Dietary Supplements |
|
|
84 | (10) |
|
8 Gene Therapy and Pharmacogenomics |
|
|
94 | (8) |
|
9 Photo Atlas of Drug Administration |
|
|
102 | (33) |
|
PART 2 Drugs Affecting the Central Nervous System |
|
|
135 | (154) |
|
|
135 | (30) |
|
11 General and Local Anesthetics |
|
|
165 | (18) |
|
12 Central Nervous System Depressants and Muscle Relaxants |
|
|
183 | (15) |
|
13 Central Nervous System Stimulants and Related Drugs |
|
|
198 | (16) |
|
|
214 | (17) |
|
|
231 | (16) |
|
16 Psychotherapeutic Drugs |
|
|
247 | (27) |
|
17 Substance Use Disorder |
|
|
274 | (15) |
|
PART 3 Drugs Affecting the Autonomic Nervous System |
|
|
289 | (46) |
|
|
289 | (14) |
|
19 Adrenergic-Blocking Drugs |
|
|
303 | (12) |
|
|
315 | (11) |
|
21 Cholinergic-Blocking Drugs |
|
|
326 | (9) |
|
PART 4 Drugs Affecting the Cardiovascular and Renal Systems |
|
|
335 | (140) |
|
22 Antihypertensive Drugs |
|
|
335 | (21) |
|
|
356 | (14) |
|
|
370 | (13) |
|
|
383 | (22) |
|
26 Coagulation Modifier Drugs |
|
|
405 | (25) |
|
|
430 | (15) |
|
|
445 | (13) |
|
29 Fluids and Electrolytes |
|
|
458 | (17) |
|
PART 5 Drugs Affecting the Endocrine and Reproductive Systems |
|
|
475 | (82) |
|
|
475 | (8) |
|
31 Thyroid and Antithyroid Drugs |
|
|
483 | (9) |
|
|
492 | (26) |
|
|
518 | (10) |
|
|
528 | (20) |
|
|
548 | (9) |
|
PART 6 Drugs Affecting the Respiratory System |
|
|
557 | (32) |
|
36 Antihistamines, Decongestants, Antitussives, and Expectorants |
|
|
557 | (13) |
|
|
570 | (19) |
|
PART 7 Antiinfective and Antiinflammatory Drugs |
|
|
589 | (111) |
|
|
589 | (25) |
|
|
614 | (17) |
|
|
631 | (20) |
|
|
651 | (11) |
|
|
662 | (9) |
|
43 Antimalarial, Antiprotozoal, and Anthelmintic Drugs |
|
|
671 | (13) |
|
44 Antiinflammatory and Antigout Drugs |
|
|
684 | (16) |
|
PART 8 Chemotherapeutic Drugs and Biologic and Immune Modifiers |
|
|
700 | (88) |
|
45 Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle-Specific Drugs |
|
|
700 | (26) |
|
46 Antineoplastic Drugs Part 2: Cell Cycle-Nonspecific and Miscellaneous Drugs |
|
|
726 | (13) |
|
47 Biologic Response-Modifying and Antirheumatic Drugs |
|
|
739 | (22) |
|
48 Immunosuppressant Drugs |
|
|
761 | (12) |
|
|
773 | (15) |
|
PART 9 Drugs Affecting the Gastrointestinal System and Nutrition |
|
|
788 | (81) |
|
50 Acid-Controlling Drugs |
|
|
788 | (13) |
|
|
801 | (14) |
|
52 Antiemetic and Antinausea Drugs |
|
|
815 | (12) |
|
|
827 | (21) |
|
|
848 | (10) |
|
55 Nutritional Supplements |
|
|
858 | (11) |
|
PART 10 Dermatologic, Ophthalmic, and Otic Drugs |
|
|
869 | (44) |
|
|
869 | (16) |
|
|
885 | (22) |
|
|
907 | (6) |
Appendix: Pharmaceutical Abbreviations |
|
913 | (1) |
Answers to Review Questions |
|
914 | (2) |
Index |
|
916 | |